학술논문
Chimeric antigen receptor modified T cells directed against CD19 (CTL019) induce clinical responses in patients with relapsed or refractory CD19+ lymphomas
Document Type
Abstract
Author
Levine, Bruce; Svoboda, Jakub; Nasta, Sunita D.; Porter, David; Chong, Elise; Lacey, Simon; Mahnke, Yolanda; Melenhorst, Joseph; Chew, Anne; Shah, Gaurav; Hasskar, Jens; Wasik, Mariusz; Landsburg, Daniel; Mato, Anthony; Garfall, Alfred; Frey, Noelle; Shaw, Pamela; Marcucci, Katherine; Shea, Joan; McConville, Holly; Manvar, Neel; O'Rourke, Matthew; Lamontagne, Anne; Bersenev, Alexey; Zheng, Zoe; Schuster, Stephen; June, Carl
Source
In Cytotherapy June 2015 17(6) Supplement:S13-S13
Subject
Language
ISSN
1465-3249